Does brain inflammation mediate pathological outcomes in epilepsy?

Advances in Experimental Medicine and Biology

Volumn 813, Issue , 2014, Pages 169-183

  Wilcox, Karen S ^a   Vezzani, Annamaria ^b  

^a UNIVERSITY OF UTAH   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

IL 1 ; IL 6; Inflammation; Reactive astrogliosis; TNF

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; AUTOANTIBODY; BELNACASAN; CYCLOOXYGENASE 2 INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; INTERLEUKIN 6; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NATALIZUMAB; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TACROLIMUS; TG 6 10 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; N METHYL DEXTRO ASPARTIC ACID; PROSTAGLANDIN E2; VOLTAGE GATED SODIUM CHANNEL;

ADAPTIVE IMMUNITY; ASTROCYTE; BLOOD BRAIN BARRIER; DISEASE ASSOCIATION; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FOCAL EPILEPSY; HUMAN; INNATE IMMUNITY; LEUKOCYTE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RASMUSSEN SYNDROME; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENCEPHALITIS; NERVE EXCITABILITY; NEUROMODULATION; NEUROPATHOLOGY; OUTCOME ASSESSMENT; SIGNAL TRANSDUCTION;

ENCEPHALITIS; EPILEPSY; HUMANS; INFLAMMATION MEDIATORS; NEURONAL PLASTICITY; SYNAPTIC TRANSMISSION;

EID: 84934440658     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-17-8914-1_14     Document Type: Review

References (134)

1. Akin D, Ravizza T, Maroso M, Carcak N, Eryigit T, Vanzulli I et al (2011) IL-1 beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-andwave discharges, and contributes to their occurrence. Neurobiol Dis 44(3):259-269
2. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22(5):208-215
3. Aronica E, Ravizza T, Zurolo E, Vezzani A (2012) Astrocyte immune responses in epilepsy. Glia 60(8):1258-1268
4. Aronica E, Sandau US, Iyer A, Boison D (2013) Glial adenosine kinase-A neuropathological marker of the epileptic brain. Neurochem Int 63:688-695
5. Auvin S, Mazarati A, Shin D, Sankar R (2010) Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol Dis 40(1):303-310
6. Auvin S, Shin D, Mazara ti A, Sankar R (2010) Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 51(Suppl 3):34-38
7. Balosso S, Maroso M, Sanchez-Alavez M, Rav izza T, Frasca A, Bartfai T et al (2008) A novel nontranscriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 131(Pt 12):3256-3265
8. Balosso S, Ravizza T, Aronica E, Vezzani A (2013) The dual role of TNF-alpha and its receptors in seizures. Exp Neurol 247C:267-271
9. Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG et al (2005) Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 57(6):804-812
10. Bauer J, Vezzani A, Bien CG (2012) Epileptic encephalitis: the role of the innate and adaptive immune system. Brain Pathol 22(3):412-421
11. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M et al (2002) Control of synaptic s trength by glial TNFalpha. Science 295(5563):2282-2285
12. Bellinger FP, Madamba S, Siggins GR (1993) Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628(1-2):227-234
13. Bien CG, Tiemeier H, Sassen R, Kuczaty S, Urbach H, von Lehe M et al (2013) Rasmussen encephalitis: incidence and course under randomize d therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 54(3):543-550
14. Bittner S Simon OJ Gobel K Bien CG Meuth SG Wiendl H 2013 Rasmussen encephalitis treated with natalizumab Neurology 81 4 395-397
15. Boison D (2013) Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev 65(3):906-943
16. Cacheaux LP, I vens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M et al (2009) Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 29(28): 8927-8935
17. C hen CJ, Ou YC, Chang CY, Pan HC, Liao SL, Chen SY et al (2012a) Glutamate released by Japanese encephalitis virus-infected microglia involves TNFalpha signaling and contributes to neuronal death. Glia 60(3):487-501
18. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB (2012b) Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 72(6):881-892
19. Collignon F, Wetjen NM, Cohen-Gadol AA, Cascino GD, Parisi J, Meyer FB et al (2006) Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans. J Neurosurg 105(1):77-87
20. Coulter DA, Eid T (2012) Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60(8): 1215-1226
21. Cusick MF, Libbey JE, Patel DC, Doty DJ, Fujinami RS (2013) Infiltrating macrophages are key to the development of seizures following virus infection. J Virol 87(3):1849-1860
22. David Y, Cacheaux LP, Ivens S, Lapilover E, Heinemann U, Kaufer D et al (2009) Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J Neurosci 29(34):10588-10599
23. Davis CN, Tabarean I, Gaidarova S, Behrens MM, Bartfai T (2006) IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem 98(5):1379-1389
24. De Simon i MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F et al (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12(7):26 23-2633
25. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36(3):174-184
26. Di em R, Hobom M, Grotsch P, Kramer B, Bahr M (2003) Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol Cell Neurosci 22(4):487-500
27. Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11(8):633-652
28. Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ (2005) Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57(1):152-155
29. Eid T, Thomas MJ, Spencer DD, Runden-Pran E, Lai JC, Malthankar GV et al (2004) Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamat e in mesial temporal lobe epilepsy. Lancet 363(9402):28-37
30. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L et al (2008) A role for leukocyte-endothelia l adhesion mechanisms in epilepsy. Nat Med 14(12):1377-1383
31. Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O et al (2004) Reversible demyelination, blood-bra in barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol 165(5):1827-1837
32. Fonseca CG, Green CR, Nicholson LF (2002) Upregulati on in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res 929(1): 105-116
33. Friedman A, Kaufer D, Heinemann U (2009) Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 85(2-3):142-149
34. Frigerio F, Frasca A, Weissberg I, Parrella S, Friedman A, Vezzani A et al (2012) Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathol ogy. Epilepsia 53(11):1887-1897
35. Furukawa K Mattson MP 1998 The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA-and AMPA/kainate-induced current s induced by tumor necrosis factor-alpha in hippocampal neurons J Neurochem 70 5 1876-1886
36. Gibbons MB, Smeal RM, Takahashi DK, Vargas JR, Wilcox KS (2013) Contributions of astrocytes t o epileptogenesis following status epilepticus: opportunities for preventive therapy? Neurochem Int 63:660-669
37. Hennessy EJ, Parker AE, O'Neill LA (2010) Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9(4):293-307
38. Hinterkeuser S, Schroder W, Hager G, Seifert G, Blumcke I, Elger CE et al (2000) Astrocytes in the hippocampus of patients with temporal lobe e pilepsy display changes in potassium conductances. Eur J Neurosci 12(6):2087-2096
39. Holtman L, van Vliet EA, Edelbroek PM, Aronica E, Gorter JA (2010) Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Res 91(1):49-56
40. Iori V, Maroso M, Rizzi M, Iyer AM, Vertemara R, Carli M et al (2013) Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 58:102-114
41. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA et a l (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51(9):1763-1773
42. Jiang J, Dingledine R (2013) Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anticancer, and neuroprotection. Trends Pharmacol Sci 34(7):413-423
43. Jiang J, Quan Y, Ganesh T, Pouliot WA, Dudek FE, Dingledine R (2013) Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proc Natl Acad Sci U S A 110(9):3591-3596
44. Jin X, Gereau RW (2006) Acute p38-med iated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factoralpha. J Neurosci 26(1):246-255
45. Jung KH, Chu K, Lee ST, Kim J, Sinn DI, Kim JM et al (2006) Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 23(2):2 37-246
46. Kawasaki Y, Zhang L, Cheng JK, Ji RR (2008) Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28(20): 5189-5194
47. Kirkman NJ, Libbey JE, Wilcox KS, White HS, Fujinami RS (2010) Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51(3):454-464
48. Koller H, Allert N, Oel D, Stoll G, Siebler M (1998) TNF alpha induces a protein kinase C-dependent reduction in astroglial K+ conductance. Neuroreport 9(7):1375-1378
49. Kovacs Z, Czurko A, Kekesi KA, Juhasz G (2011) Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG/Rij rats. Brain Res Bull 85(6): 410-416
50. Kulkarni SK, Dhir A (2009) Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc) 45(2):135-154
51. Kunz T, Oliw EH (2001) The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur J Neurosci 13(3):569-575
52. Kwon YS, Pineda E, Auvin S, Shin D, Mazarati A, Sankar R (2013) Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J Neuroinflammation 10:30
53. Lai AY, Swayze RD, El-Husseini A, Song C (2006) Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 175(1-2):97-106
54. Lalic T, Pettingill P, Vincent A, Capogna M (2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia 52(1):121-131
55. Leonoudakis D, Braithwaite SP, Beattie MS, Beattie EC (2004) TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? Neuron Glia Biol 1(3):263-273
56. Leonoudakis D Zhao P Beattie EC 2008 Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity J Neurosci 28 9 2119-2130
57. Libbey JE, Kirkman NJ, Smith MC, Tanaka T, Wilcox KS, White HS et al (2008) Seizures following picornavirus infection. Epilepsia 49(6): 1066-1074
58. Librizzi L, Noe F, Vezzani A, de Curtis M, Ravizza T (2012) Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 72(1):82-90
59. Librizzi L, Regondi MC, Pastori C, Frigerio S, Frasso ni C, de Curtis M (2007) Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 48(4):743-751
60. Lund IV, Hu Y, Raol YH, Benham RS, Faris R, Russek SJ et al (2008) BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci Signal 1(41):ra9
61. Ma L, Cui XL, Wang Y, Li XW, Yang F, Wei D et al (2012) Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pi locarpine-induced status epilepticus in rats. Brain Res 1469:103-113
62. Mandolesi G, Musella A, Gentile A, Grasselli G, Haji N, Sepman H et al (2013) Interleukin-1beta alters glutamate t ransmission at purkinje cell synapses in a mouse model of multiple sclerosis. J Neurosci 33(29):12105-12121
63. Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J (2010) In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis 5:31
64. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G et al (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33(2):171-181
65. Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, Desai NK et al (2010) Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res 1353:176-186
66. Maroso M, Balosso S, Ravizza T, Iori V, Wright C I, French J et al (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8(2):304-315
67. Maroso M, Balo sso S, Ravizza T, Liu J, Aronica E, Iyer AM et al (2010) Toll-like receptor 4 and highmobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16(4):413-419
68. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC et al (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52(3):453-472
69. Morin-Brureau M, Lebrun A, Rousset MC, Fagni L, Bockaert J, de Bock F et al (2011) Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organo typic hippocampal cultures: role of VEGF signaling pathways. J Neurosci 31(29):10677-10688
70. Naus CC, Bechberger JF, Caveney S, Wilson JX (1991) Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci Lett 126(1):33-36
71. Nehlig A (2007) What is animal experimentation telling us about new drug treatments of status epilepticus? Epilepsia 48(Suppl 8):78-81
72. Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C et al (2012) The Jak/STAT pathway is involved in synaptic plasticity. Neuron 73(2): 374-390
73. N icoletti JN, Shah SK, McCloskey DP, Goodman JH, Elkady A, Atassi H et al (2008) Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience 151(1):232-241
74. Noe FM, Polascheck N, Frigerio F, Bankstahl M, Ravizza T, Marchini S et al (2013) Pharmacological blockade of IL-1beta/IL-1 receptor type 1 axis durin g epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 59:183-193
75. O'Donnell E, Vereker E, Lynch MA (2000) Agerelated impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur J Neurosci 12(1):345-352
76. Oberheim NA, Tian GF, Han X, Peng W, Takano T, Ransom B et al (2008) Loss of astrocytic domain organization in the epileptic brain. J Neurosci 28(13):3264-3276
77. Oby E, Janigro D (2006) The blood-brain barrier and epilepsy. Epilepsia 47(11):1761-1774
78. Ortinski PI Dong J Mungenast A Yue C Takano H Watson DJ et al 2010 Se lective induction of astrocytic gliosis generates deficits in neuronal inhibition Nat Neurosci 13 5 584-591
79. Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM (2004) The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 45(5):516-526
80. Pedrazzi M, Averna M, Sparatore B, Patrone M , Salamino F, Marcoli M et al (2012) Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS One 7(8):e44518
81. Pedrazzi M, Raiteri L , Bonanno G, Patrone M, Ledda S, Passalacqua M et al (2006) Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J Neurochem 99(3): 827-838
82. Pernhorst K, Herms S, Hoffmann P, Cichon S, Schulz H, Sander T et al (2013) TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epilepti c brain tissue. Seizure 22(8):675-678
83. Plata-Salaman CR, Ffrench-Mullen JM (1992) Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Br ain Res Bull 29(2):221-223
84. Plata-Salaman CR, ffrench-Mullen JM (1994) Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 266(1):1-10
85. Polascheck N, Bankstahl M, Loscher W (2010) The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 224(1):219-233
86. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH et al (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant tem poral lobe epilepsy. Brain 125(Pt 1):32-43
87. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F et al (2006) Inactivation of caspase-1 in rodent brain: a novel anticonvulsive stra tegy. Epilepsia 47(7):1160-1168
88. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A (2008) Interleukin converting enzyme inhibition impairs kindling epileptogenesis in r ats by blocking astrocytic IL-1beta production. Neurobiol Dis 31(3):327-333
89. Riazi K, Galic MA, Pittman QJ (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89(1):34-42
90. Rodgers K M, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS (2009) The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 132(Pt 9):2478-2486
91. Sanchez-Alavez M, Tabarean IV, Behrens MM, Bartfai T (2006) Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc Natl Acad Sci U S A 103(8):2904-2908
92. Santello M, Bezzi P, Volterra A (2011) TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69(5):988-1001
93. Santello M, Volterra A (2012) TNFalpha in synaptic function: switching gears. Trends Neurosci 35(10):638-647
94. Sarac S, Afzal S, Broholm H, Madsen FF, Ploug T, Laursen H (2009) Excitatory amino acid transporters EAAT-1 and EAAT-2 in te mporal lobe and hippocampus in intractable temporal lobe epilepsy. APMIS 117(4):291-301
95. Schafers M, Sorkin L (2008) Effect of cytokines on neuronal excitability. Neurosci Lett 437(3):188-193
96. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A 95(13):7778-7783
97. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U et al (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex . J Neurosci 24(36):7829-7836
98. Smeal RM, Stewart KA, Iacob E, Fujinami RS, White HS, Wilcox KS (2012) The activity within the CA3 excitatory network during Theiler's virus encephaliti s is distinct from that observed during chronic epilepsy. J Neurovirol 18(1):30-44
99. Sofroniew MV 2009 Molecular dissection of reactive astrogliosis and glial scar formation Trends Neurosci 32 12 638-647
100. Sotgiu S, Murrighile MR, Constantin G (2010) Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurol 10:84
101. Steinmetz CC, Turrigiano GG (2010) Tumor necrosis factor-alpha signaling maintains the ability of cortical synapses to express synaptic scaling. J Neurosci 30(44):14685-14690
102. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factoralpha. J Neurosci 25(12):3219-3228
103. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087): 1054-1059
104. Stewart KA, Wilcox KS, Fujinami RS, White HS (2010) Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice. J Neuropathol Exp Neurol 69(12):1210-1219
105. Tabarean IV, Korn H, Bartfai T (2006) Interleukin-1beta i nduces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience 141(4):1685-1695
106. Takahashi DK, Vargas JR, Wilcox KS (2010) Increased coupl ing and altered glutamate transport currents in astrocytes following kainic-acid-induced status epilepticus. Neurobiol Dis 40(3):573-585
107. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R et al (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281(30):21362-21368
108. Th eodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacobson S (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49(11):1828-1837
109. Uva L, Librizzi L, Marchi N, Noe F, Bongiovanni R, Vezzani A et al (2008) Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscie nce 151(1):303-312
110. van Gassen KL, de Wit M, Koerkamp MJ, Rensen MG, van Rijen PC, Holstege FC et al (2008) Possible role of the innate immunity in temporal lobe epilepsy. Epi lepsia 49(6):1055-1065
111. van Vliet EA, Zibell G, Pekcec A, Schlichtiger J, Edelbroek PM, Holtman L et al (2010) COX-2 inhibition controls P-glycoprotein expression and promotes brain d elivery of phenytoin in chronic epileptic rats. Neuropharmacology 58(2):404-412
112. Vargas JR, Takahashi DK, Thomson KE, Wilcox KS (2013) The expression of kainate receptor subunits in hippocam pal astrocytes after experimentally induced status epilepticus. J Neuropathol Exp Neurol 72(10):919-932
113. Vezzani A, Balosso S, Maroso M, Zardoni D, Noe F, Ravizza T (2010) ICE/caspas e 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11(1):43-50
114. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F et al (1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19(12):5054-50 65
115. Vezzani A, French J, Bartfai T, Baram TZ (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7(1):31-40
116. Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69:16-24
117. Vezzani A, Janigro D (2009) Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers. Epilepsy Curr 9(4):118-121
118. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25(7):1281-1289
119. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A et al (2000) Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Nat l Acad Sci U S A 97(21):11534-11539
120. Vincent A Irani SR Lang B 2011) Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia 52(Suppl 8): 8-11
121. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T et al (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23(25):8692-8700
122. Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247-263
123. Wang S, Cheng Q, Malik S, Yang J (2000) Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 292(2):497-504
124. Weinberg MS, Blake BL, McCown TJ (2013) Opposing actions of hippocampus TNFalpha receptors on limbic seizure susceptibility. Exp Neurol 247:429-437
125. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M et al (2006) Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 103(46):17513-17518
126. Yin HZ, Hsu CI, Yu S, Rao SD, Sorkin LS, Weiss JH (2012) TNF-alpha triggers rapid membrane insertion of Ca(2+) permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury. Exp Neurol 238(2):93-102
127. Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25(2):181-213
128. Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K et al (2011) Brain infiltration of leukocytes contributes to the pathophysiology of temporal l obe epilepsy. J Neurosci 31(11): 4037-4050
129. Zeise ML, Espinoza J, Morales P, Nalli A (1997) Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and denta te gyrus granule cells of the rat in vitro. Brain Res 768(1-2):341-344
130. Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42(5):1420-1428
131. Zhang R, Sun L, Hayashi Y, Liu X, Koyama S, Wu Z et al (2010) Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta. Neurobiol Dis 38( 1):68-77
132. Zhou C, Tai C, Ye HH, Ren X, Chen JG, Wang SQ et al (2006a ) Interleukin-1beta downregulates the L-type Ca2+ channel activity by depressing the expression of channel protein in cor tical neurons. J Cell Physiol 206(3):799-806
133. Zhou C, Ye HH, Wang SQ, Chai Z (2006b ) Interleukin-1beta regulation of N-type Ca2+ channels in cortical neurons. Neurosci Lett 403(1-2):181-185
134. Zurolo E, de Groot M, Iyer A, Anink J, van Vliet EA, Heimans JJ et al (2012) Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleuki n-1 beta. J Neuroinflammation 9:280